STOCK TITAN

Telescope Announces Debt Settlement Transaction

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Telescope Innovations (OTCQB: TELIF) announced a debt settlement on October 23, 2025, issuing a total of 689,654 common shares at a deemed price of CAD $0.29 per share.

The issuance settles CAD $100,000 of indebtedness to Jason Hein, CTO and director, via 344,827 shares, and CAD $100,000 of a secured loan via 344,827 shares. The secured loan originally provided CAD $1,200,000, bears 6.95% annual interest and matures on June 1, 2026.

Hein is a related party under MI 61-101; the company relied on exemptions to formal valuation and minority approval. All issued shares carry a statutory hold of four months and one day. Completion is subject to Canadian Securities Exchange and other regulatory approvals.

Loading...
Loading translation...

Positive

  • Settles CAD 100,000 indebtedness to CTO via equity
  • Settles CAD 100,000 of secured loan through share issuance

Negative

  • Issues 689,654 shares at CAD 0.29 per share (dilution risk)
  • Related party transaction with CTO Jason Hein under MI 61-101
  • Completion subject to CSE and other regulatory approvals

News Market Reaction 1 Alert

+4.75% News Effect

On the day this news was published, TELIF gained 4.75%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Vancouver, British Columbia--(Newsfile Corp. - October 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce that it has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a "Share") of the Company (the "Debt Settlement").

Pursuant to the Debt Settlement, the Company has reached an agreement with Jason Hein, Chief Technology Officer and a director of the Company, to settle an aggregate of CAD $100,000 in outstanding indebtedness (the "Indebtedness") incurred for services previously provided to the Company. The Indebtedness will be satisfied through the issuance of 344,827 Shares of the Company at a deemed price of CAD $0.29 per Share.

In addition, the Company previously entered into a secured loan facility (the "Loan") with a group of lenders, pursuant to which the Company received aggregate proceeds of CAD $1,200,000 to support operational activities. The Loan bears interest at a rate of 6.95% per annum and matures on June 1, 2026. The Company has agreed to settle $100,000 of the Loan, through the issuance of 344,827 Shares at a deemed price of CAD $0.29 per Share.

Jason Hein is a director and officer of the Company and therefore a "related party" within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The participation by Hein in the Debt Settlement constitutes a "related party transaction" under MI 61-101. The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements set out in sections 5.5(a) and 5.7(1)(a) of MI 61-101, respectively, on the basis that the fair market value of the securities issued to Hein does not exceed 25% of the Company's market capitalization.

All Shares issued pursuant to the Debt Settlement will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable Canadian securities laws. Completion of the Debt Settlement remains subject to the approval of the Canadian Securities Exchange and all other required regulatory approvals.

About Telescope Innovations

Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company's aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.

On behalf of the Board,

Telescope Innovations Corp.

Henry Dubina, CEO

For additional information, please contact

Jeffrey Sherman
E: jeff@telescopeinn.com

Forward-Looking Information

The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain certain "forward-looking information" under applicable Canadian securities laws. When or if used in this news release, the words "anticipate," "believe," "estimate," "expect." "target", "plan," "forecast," "may," "schedule," and similar words or expressions identify forward-looking information. This forward-looking information may relate to planned project development, exploration programs, the intended use of the proceeds from the Offering and other factors or information.

Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. The forward-looking information contained in this news release is made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271662

FAQ

What did Telescope (TELIF) announce on October 23, 2025?

Telescope announced a debt settlement issuing 689,654 shares at CAD $0.29 to settle CAD $200,000 of obligations.

How much debt was settled with CTO Jason Hein in the TELIF transaction?

TELIF settled CAD $100,000 of indebtedness to Jason Hein via 344,827 shares at CAD $0.29 each.

What loan terms related to TELIF’s settlement should investors note?

The secured loan funded CAD $1,200,000, bears 6.95% interest and matures on June 1, 2026; CAD $100,000 was settled with shares.

Are the TELIF shares issued in the debt settlement restricted?

Yes; all shares issued are under a statutory hold period of four months and one day from issuance.

Was the Telescope (TELIF) debt settlement a related party transaction?

Yes; Jason Hein is a director and officer, so the settlement is a related party transaction under MI 61-101.

Is the TELIF debt settlement final or subject to approvals?

The settlement is subject to approval by the Canadian Securities Exchange and other required regulatory approvals.
TELESCOPE INNOVATIONS CORP

OTC:TELIF

TELIF Rankings

TELIF Latest News

TELIF Stock Data

14.25M
66.29M
23.53%
Biotechnology
Healthcare
Link
Canada
Vancouver